2024 annual financial data
Krystal Biotech 2024 Operating cash flow growth
Direct answer
Operating cash flow growth was 238.98%.
Operating income was 65,695,000 USD and net income was 89,159,000 USD.
Operating cash flow was 123,420,000 USD.
Get free Krystal Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 290,515,000 USD
- Operating income
- 65,695,000 USD
- Net income
- 89,159,000 USD
- Operating cash flow
- 123,420,000 USD